KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

[Postoperative Management of Aneurysmal Subarachnoid Hemorrhage].

Hiroyuki Sakata, Hidenori Endo

No Shinkei Geka 52(5) 906-913

PMID39285539
PMCID-
DOI10.11477/mf.1436204998
发表日期2024-09-17
摘要

摘要

Delayed cerebral ischemia(DCI) is one of the most significant complications of subarachnoid hemorrhage. Despite significant evolution in understanding DCI pathophysiology, vasospasm affecting cerebral vessels of large and moderate diameters remain the only clinically measurable component of DCI and is therefore the primary target for intervention in the postoperative management of subarachnoid hemorrhage. In Japan, fasudil hydrochloride and ozagrel sodium are widely used to prevent vasospasms; however, their effects are sometimes insufficient. Clazosentan, a selective endothelin receptor subtype A antagonist, reduces vasospasm-related morbidity and all-cause mortality following aneurysmal subarachnoid hemorrhage. This was demonstrated in a recent randomized phase 3 trial, leading to the approval of clazosentan by the Pharmaceuticals and Medical Devices Agency in Japan. Recent advances in our understanding of subarachnoid hemorrhage will facilitate improved management to reduce the incidence of DCI.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。